Trial Profile
Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2023
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Adverse reactions; Pharmacokinetics
- Acronyms PBTC-047
- 08 Apr 2022 Planned End Date changed from 31 Dec 2024 to 31 Mar 2024.
- 11 Feb 2022 Planned End Date changed from 1 Oct 2023 to 31 Dec 2024.
- 11 Feb 2022 Planned primary completion date changed from 31 Dec 2022 to 31 Mar 2022.